Derailed Ceramide Metabolism in Atopic Dermatitis (AD): A Causal Starting Point for a Personalized (Basic) Therapy
Author: | Markus Blaess, Hans-Peter DeignerORCiDGND |
---|---|
URN: | https://urn:nbn:de:bsz:fn1-opus4-61063 |
DOI: | https://doi.org/10.3390/ijms20163967 |
ISSN: | 1422-0067 |
Parent Title (English): | International Journal of Molecular Sciences |
Document Type: | Article (peer-reviewed) |
Language: | English |
Year of Completion: | 2019 |
Release Date: | 2020/01/22 |
Tag: | Amitriptyline; Antioxidants; Apoptosis; Atopic dermatitis; Ceramide de novo synthesis; Ceramide metabolism; Linoleic acid; Lysosome; Lysosomotropic compounds; Sphingolipid profile |
Volume: | 20.2019 |
Issue: | 16 Article 3967 |
Page Number: | 15 |
Open-Access-Status: | Open Access |
Licence (German): | Creative Commons - CC BY - Namensnennung 4.0 International |